Efficacy and Safety of First-Line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma

JAMA Oncology - United States
doi 10.1001/jamaoncol.2018.0077
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

PD-L1 Inhibition With Avelumab for Metastatic Merkel Cell Carcinoma

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2018English

Minimal Impact on Patients’ Health Utilities Associated With Adverse Events in Metastatic Merkel Cell Carcinoma Patients on Treatment With Avelumab

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Updated Efficacy of Avelumab in Patients With Previously Treated Metastatic Merkel Cell Carcinoma After ≥1 Year of Follow-Up: JAVELIN Merkel 200, a Phase 2 Clinical Trial

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Avelumab in the Treatment of Patients With Merkel Cell Carcinoma: Initial Results of Early Access Program in Russia

Malignant tumours
2019English

Mo2 - Modelling Overall Survival in Immunotherapy Using Parametric Techniques: Avelumab in Previously Treated Metastatic Merkel Cell Carcinoma

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Diffuse Lichen Planus-Like Keratoses and Clinical Pseudo-Progression Associated With Avelumab Treatment for Merkel Cell Carcinoma, a Case Report

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Development and Validation of a Prognostic Index for Efficacy Evaluation and Prognosis of First-Line Chemotherapy in Stage III–IV Lung Squamous Cell Carcinoma

European Radiology
MedicineNuclear MedicineRadiologyImaging
2019English

Do Tyrosine Kinase Inhibitors Lose Favor in Treatment of First-Line Metastatic Renal Cell Carcinoma?

Future Oncology
MedicineCancer ResearchOncology
2019English

Immunotherapy for the First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy